Literature DB >> 28839706

Pharmacy-led switches of 5-ASA: impact on secondary care.

Chris J Healey1, John O'Malley2.   

Abstract

Entities:  

Keywords:  5-Aminosalicylic Acid (5-Asa); Crohn's Disease; Inflammatory Bowel Disease; Ulcerative Colitis

Year:  2012        PMID： 28839706      PMCID： PMC5369795          DOI： 10.1136/flgastro-2012-100210

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  11 in total

1.  European evidence-based Consensus on the management of ulcerative colitis: Current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; W A Bemelman; Y Chowers; J F Colombel; G D'Haens; S Ghosh; P Marteau; W Kruis; N J McC Mortensen; F Penninckx; M Gassull
Journal:  J Crohns Colitis       Date:  2008-01-18       Impact factor: 9.071

2.  What happens to patients who have their asthma device switched without their consent?

Authors:  Scott Doyle; Andrew Lloyd; Angela Williams; Henry Chrystyn; Mandy Moffat; Mike Thomas; David Price
Journal:  Prim Care Respir J       Date:  2010-06

3.  The fight for 'health-related normality': a qualitative study of the experiences of individuals living with established inflammatory bowel disease (ibd).

Authors:  Nicola J Hall; Gregory P Rubin; Audrey Dougall; A P S Hungin; Joanne Neely
Journal:  J Health Psychol       Date:  2005-05

4.  Antiepileptic drugs: the drawbacks of generic substitution.

Authors: 
Journal:  Lancet Neurol       Date:  2010-03       Impact factor: 44.182

5.  Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Authors:  Fernando S Velayos; Jonathan P Terdiman; Judith M Walsh
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

6.  Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey.

Authors:  Subrata Ghosh; Rod Mitchell
Journal:  J Crohns Colitis       Date:  2007-09       Impact factor: 9.071

Review 7.  Management of stress in inflammatory bowel disease: a therapeutic option?

Authors:  James R Goodhand; Mahmood Wahed; David S Rampton
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 3.869

8.  Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease.

Authors:  Rob Horne; Rhian Parham; Richard Driscoll; Andrew Robinson
Journal:  Inflamm Bowel Dis       Date:  2009-06       Impact factor: 5.325

9.  Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.

Authors:  Sunanda Kane; Dezheng Huo; James Aikens; Stephen Hanauer
Journal:  Am J Med       Date:  2003-01       Impact factor: 4.965

10.  Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication.

Authors:  Kore Liow
Journal:  BMC Neurol       Date:  2009-03-17       Impact factor: 2.474
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.